| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Epidemiology and Prevention |
1 Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland and 2 Department of Epidemiology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas
Requests for reprints: Eric A. Engels, Viral Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Boulevard, EPS 7076, Rockville, MD 20892. E-mail: engelse{at}exchange.nih.gov.
Inflammatory responses to environmental exposures, such as tobacco smoke, may play a role in lung carcinogenesis. To test this hypothesis, we studied genetic polymorphisms in the inflammation pathway in relation to lung cancer risk. We evaluated a panel of 59 single nucleotide polymorphisms (SNP) in 37 inflammation-related genes among non-Hispanic Caucasian lung cancer cases (N = 1,553) and controls (N = 1,730) from Houston, Texas. Logistic regression was used to assess associations with lung cancer under a dominant genetic model adjusted for sex, age, and smoking. Haplotypes were estimated with the expectation-maximization algorithm. False-positive report probabilities (FPRP) were calculated for significant associations. Interleukin 1ß (IL1B) C3954T was associated with lung cancer [odds ratio (OR), 1.27; 95% confidence interval (95% CI), 1.10–1.47; FPRP 0.148]. Two IL1A SNPs (C-889T and Ala114Ser) were also related to lung cancer (OR, 1.18–1.22), although FPRPs were higher. One IL1A-IL1B haplotype, containing only the IL1B 3954T allele, was associated with elevated lung cancer risk (OR, 1.80; 95% CI, 1.24–2.61). These associations were stronger in heavy smokers, particularly for IL1B C3954T (OR, 1.59; 95% CI, 1.28–1.97; FPRP 0.004). Lung cancer risk was unrelated to polymorphisms in IL1 receptor or antagonist genes. Associations with lung cancer were also seen for SNPs in granulocyte macrophage colony stimulating factor and peroxisome proliferator-activated factor-
, but FPRPs were high. IL1A and IL1B polymorphisms are associated with increased lung cancer risk, especially among heavy smokers. IL1A and IL1B are critical signals in initiating inflammation. Our results suggest that a dysregulated inflammatory response to tobacco-induced lung damage promotes carcinogenesis. [Cancer Res 2007;67(13):6520–7]
This article has been cited by other articles:
|
|
 |
|
  L. Wang, Y. Xiong, Y. Sun, Z. Fang, L. Li, H. Ji, and T. Shi HLungDB: an integrated database of human lung cancer research Nucleic Acids Res., November 9, 2009; (2009) gkp945v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. C. Reyes-Gibby, M. R. Spitz, S. Yennurajalingam, M. Swartz, J. Gu, X. Wu, E. Bruera, and S. Shete Role of Inflammation Gene Polymorphisms on Pain Severity in Lung Cancer Patients Cancer Epidemiol. Biomarkers Prev., October 1, 2009; 18(10): 2636 - 2642. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R P Young, R J Hopkins, B A Hay, M J Epton, G D Mills, P N Black, H D Gardner, R Sullivan, and G D Gamble A gene-based risk score for lung cancer susceptibility in smokers and ex-smokers Postgrad. Med. J., October 1, 2009; 85(1008): 515 - 524. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. E. Landvik, K. Hart, V. Skaug, L. B. Stangeland, A. Haugen, and S. Zienolddiny A specific interleukin-1B haplotype correlates with high levels of IL1B mRNA in the lung and increased risk of non-small cell lung cancer Carcinogenesis, July 1, 2009; 30(7): 1186 - 1192. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Van Dyke, M. L. Cote, A. S. Wenzlaff, W. Chen, J. Abrams, S. Land, C. N. Giroux, and A. G. Schwartz Cytokine and Cytokine Receptor Single-Nucleotide Polymorphisms Predict Risk for Non-Small Cell Lung Cancer among Women Cancer Epidemiol. Biomarkers Prev., June 1, 2009; 18(6): 1829 - 1840. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. Bauer and E. A. Rondini REVIEW PAPER: The Role of Inflammation in Mouse Pulmonary Neoplasia Vet. Pathol., May 1, 2009; 46(3): 369 - 390. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Duffield-Lillico, J. O. Boyle, X. K. Zhou, A. Ghosh, G. S. Butala, K. Subbaramaiah, R. A. Newman, J. D. Morrow, G. L. Milne, and A. J. Dannenberg Levels of Prostaglandin E Metabolite and Leukotriene E4 Are Increased in the Urine of Smokers: Evidence that Celecoxib Shunts Arachidonic Acid into the 5-Lipoxygenase Pathway Cancer Prevention Research, April 1, 2009; 2(4): 322 - 329. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-Y. Yu, P. F. Pinsky, N. E. Caporaso, N. Chatterjee, M. Baumgarten, P. Langenberg, J. P. Furuno, Q. Lan, and E. A. Engels Lung Cancer Risk Following Detection of Pulmonary Scarring by Chest Radiography in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Arch Intern Med, November 24, 2008; 168(21): 2326 - 2332. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. D. Foulkes Inherited Susceptibility to Common Cancers N. Engl. J. Med., November 13, 2008; 359(20): 2143 - 2153. [Full Text] [PDF]
|
|
|
|
|
|
K. Steiling, J. Ryan, J. S. Brody, and A. Spira The Field of Tissue Injury in the Lung and Airway Cancer Prevention Research, November 1, 2008; 1(6): 396 - 403. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ter-Minassian, R. Zhai, K. Asomaning, L. Su, W. Zhou, G. Liu, R. S. Heist, T. J. Lynch, J. C. Wain, X. Lin, et al. Apoptosis gene polymorphisms, age, smoking and the risk of non-small cell lung cancer Carcinogenesis, November 1, 2008; 29(11): 2147 - 2152. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Dubinett, D. R. Aberle, D. P. Tashkin, and J. T. Mao The Partners--Airflow Obstruction, Emphysema, and Lung Cancer Am. J. Respir. Crit. Care Med., October 1, 2008; 178(7): 665 - 666. [Full Text] [PDF]
|
|
|
|
 |
|
 N. J. Serkova, Z. Van Rheen, M. Tobias, J. E. Pitzer, J. E. Wilkinson, and K. A. Stringer Utility of magnetic resonance imaging and nuclear magnetic resonance-based metabolomics for quantification of inflammatory lung injury Am J Physiol Lung Cell Mol Physiol, July 1, 2008; 295(1): L152 - L161. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Bethke, E. Webb, A. Murray, M. Schoemaker, C. Johansen, H. C. Christensen, K. Muir, P. McKinney, S. Hepworth, P. Dimitropoulou, et al. Comprehensive analysis of the role of DNA repair gene polymorphisms on risk of glioma Hum. Mol. Genet., March 15, 2008; 17(6): 800 - 805. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
